FUNI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
FUNI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Hypha Labs's 1-Year ROIIC % for the quarter that ended in Jun. 2024 was 172.59%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Hypha Labs's 1-Year ROIIC % or its related term are showing as below:
The historical data trend for Hypha Labs's 1-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hypha Labs Annual Data | |||||||||||||||||||||
Trend | Sep14 | Sep15 | Sep16 | Sep17 | Sep18 | Sep19 | Sep20 | Sep21 | Sep22 | Sep23 | |||||||||||
1-Year ROIIC % | Get a 7-Day Free Trial | -206.45 | 41.55 | 71.99 | -37.48 | 317.49 |
Hypha Labs Quarterly Data | ||||||||||||||||||||
Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | |
1-Year ROIIC % | Get a 7-Day Free Trial | 63.27 | 317.49 | 30.59 | 145.05 | 172.59 |
For the Diagnostics & Research subindustry, Hypha Labs's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Hypha Labs's 1-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Hypha Labs's 1-Year ROIIC % falls into.
Hypha Labs's 1-Year ROIIC % for the quarter that ended in Jun. 2024 is calculated as:
1-Year ROIIC % | = | 1-Year Incremental Net Operating Profit After Taxes (NOPAT)** | / | 1-Year Incremental Invested Capital |
= | ( -4.8364 (Jun. 2024) - -0.784 (Jun. 2023) ) | / | ( 1.095 (Jun. 2024) - 3.443 (Jun. 2023) ) | |
= | -4.0524 | / | -2.348 | |
= | 172.59%*** |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Hypha Labs (OTCPK:FUNI) 1-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Thank you for viewing the detailed overview of Hypha Labs's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.
A Stone Douglass | director | 10200 WILLOW CREEK ROAD, SAN DIEGO CA 92131 |
Edmond Defrank | director | 19360 RINALDI STREET, #448, NORTHRIDGE CA 91326 |
Kyle Remenda | officer: Chief Executive Officer | 111-2532 SHORELINE DRIVE, LAKE COUNTRY A1 V4V2R6 |
Dennis Hartmann | director | 1600 CAMDEN AVENUE, NO. 103, LOS ANGELES CA 90025 |
Bruce I Raben | director | 430 VICTORIA TERRACE, RIDGEFIELD NJ 7657 |
Cindy Sue Orser | director | 4507 APPLE WAY, BOULDER CO 80301 |
Alfredo Axtmayer | director | 287 PAYNE DRIVE, CHESHIRE CT 06410 |
Joseph J Bianco | director | 611 BROADWAY,, SUITE 307, NEW YORK NY 10012 |
Todd A Peterson | officer: Chief Financial Officer | 3608 MALLARDWOOD DRIVE, LAS VEGAS NV 89129 |
Joe D Tanner | director | 28720 ROADSIDE DRIVE, SUITE 128, AGOURA HILLS CA 91301 |
Raw Alternative, Llc | 10 percent owner | 16030 VENTURA BLVD. SUITE 380, ENCINO CA 91436 |
Todd Denkin | director, officer: President | C/O PHOTOTRON, INC., 20259 VENTURA BLVD., WOODLAND HILLS CA 91364 |
Barbee Denny Barbee | 10 percent owner | 3105 EAST CENTRAL, #114, WICHITA KS 67214 |
Eric Stoppenhagen | director, 10 percent owner, officer: CFO | 8908 SPLITARROW DRIVE, AUSTIN TX 78717 |
From GuruFocus
By ACCESSWIRE • 04-29-2024
By ACCESSWIRE • 09-26-2024
By ACCESSWIRE • 07-31-2024
By GuruFocusNews GuruFocusNews • 01-04-2022
By ACCESSWIRE • 06-11-2024
By Value_Insider Value_Insider • 12-08-2022
By ACCESSWIRE • 09-16-2024
By Marketwired • 08-29-2023
By ACCESSWIRE • 07-20-2024
By ACCESSWIRE • 04-22-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.